These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 17981734
1. Chemokines in idiopathic inflammatory myopathies. De Paepe B, Creus KK, De Bleecker JL. Front Biosci; 2008 Jan 01; 13():2548-77. PubMed ID: 17981734 [Abstract] [Full Text] [Related]
2. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses. De Paepe B, Creus KK, De Bleecker JL. Ann N Y Acad Sci; 2007 Aug 01; 1109():441-53. PubMed ID: 17785333 [Abstract] [Full Text] [Related]
3. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies. De Paepe B, De Keyzer K, Martin JJ, De Bleecker JL. Acta Neuropathol; 2005 Jun 01; 109(6):576-82. PubMed ID: 15937690 [Abstract] [Full Text] [Related]
4. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. De Paepe B, Creus KK, Martin JJ, Weis J, De Bleecker JL. Ann N Y Acad Sci; 2009 Sep 01; 1173():463-9. PubMed ID: 19758187 [Abstract] [Full Text] [Related]
5. Idiopathic inflammatory myopathies and the classical NF-kappaB complex: current insights and implications for therapy. Creus KK, De Paepe B, De Bleecker JL. Autoimmun Rev; 2009 Jun 01; 8(7):627-31. PubMed ID: 19232550 [Abstract] [Full Text] [Related]
8. [Idiopathic inflammatory myopathies. A review]. Acosta I, Matamala JM, Jara P, Pino F, Gallardo A, Verdugo R. Rev Med Chil; 2019 Mar 01; 147(3):342-355. PubMed ID: 31344172 [Abstract] [Full Text] [Related]
9. The pathological diagnosis of specific inflammatory myopathies. Carpenter S, Karpati G. Brain Pathol; 1992 Jan 01; 2(1):13-9. PubMed ID: 1341942 [Abstract] [Full Text] [Related]
10. [Inflammatory myopathies: diagnosis and classifications]. Dimitri D. Presse Med; 2009 Jan 01; 38(7-8):1141-63. PubMed ID: 19282137 [Abstract] [Full Text] [Related]
11. Immunolocalization of FAS and FAS ligand in inflammatory myopathies. De Bleecker JL, Meire VI, Van Walleghem IE, Groessens IM, Schröder JM. Acta Neuropathol; 2001 Jun 01; 101(6):572-8. PubMed ID: 11515785 [Abstract] [Full Text] [Related]
12. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects]. Eymard B. Presse Med; 2003 Oct 25; 32(35):1656-67. PubMed ID: 14631270 [Abstract] [Full Text] [Related]
17. New developments in the role of cytokines and chemokines in inflammatory myopathies. Lundberg IE, Nyberg P. Curr Opin Rheumatol; 1998 Nov 25; 10(6):521-9. PubMed ID: 9812212 [Abstract] [Full Text] [Related]
18. Acquired immune and inflammatory myopathies: pathologic classification. Pestronk A. Curr Opin Rheumatol; 2011 Nov 25; 23(6):595-604. PubMed ID: 21934500 [Abstract] [Full Text] [Related]
19. Local expression of cytokines in idiopathic inflammatory myopathies. Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF. Neuropathol Appl Neurobiol; 1998 Feb 25; 24(1):73-9. PubMed ID: 9549732 [Abstract] [Full Text] [Related]
20. Beta-chemokine receptor expression in idiopathic inflammatory myopathies. De Paepe B, De Bleecker JL. Muscle Nerve; 2005 May 25; 31(5):621-7. PubMed ID: 15772970 [Abstract] [Full Text] [Related] Page: [Next] [New Search]